| Trial ID: | L0376 |
| Source ID: | NCT06706271
|
| Associated Drug: |
Vitamin D
|
| Title: |
The Effect of Vitamin D3 Supplementation on Hepcidin and Ferritin Serum Levels in Children With Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease Stage 1|Chronic Kidney Disease Stage 2
|
| Interventions: |
DRUG: Vitamin D
|
| Outcome Measures: |
Primary: Vitamin D Level, Vitamin D is measured before and after supplementation of Vitamin D, From enrollment to the end of treatment at 6 weeks|Ferritin Level, Ferritin level before and after Vitamin D supplementation, From enrollment to the end of treatment at 6 weeks|Hepcidin level, Hepcidin level before and after Vitamin D supplementation, From enrollment to the end of treatment at 6 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Hasanuddin University
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
43
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2023-05-01
|
| Completion Date: |
2024-09-02
|
| Results First Posted: |
|
| Last Update Posted: |
2024-11-27
|
| Locations: |
Wahidin Sudirohusodo Hospital, Makassar, South Sulawesi, 90245, Indonesia
|
| URL: |
https://clinicaltrials.gov/show/NCT06706271
|
